Women aged 65 years or younger who underwent surgery and adjuvant chemotherapy for gynecologic cancer appeared at higher risk for osteopenia and osteoporosis as early as 1 year after treatment, according to study results presented at the virtual Society of Gynecologic Cancer Annual Meeting.

“There are safe and effective treatments for osteoporosis available; however, timely identification of those at risk is required for successful treatment. Our data indicate the importance of identifying women at risk soon after cancer treatments — ideally within the first year,” Janelle Sobecki, MD, clinical instructor and fellow of gynecologic oncology in the department of obstetrics and gynecology at University of Wisconsin School of Medicine and Public Health, told Healio.